Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that Frank D.

Laughing Water Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Lifecore’s board of directors has approved that holders of record of Lifecore’s Common Stock and Convertible Preferred Stock as of the close of business on February 18, 2025 (the “Record Date”), will ...

CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing ...

Lifecore Biomedical, Inc. announced plans to hold a special stockholders meeting on April 10, 2025, to seek approval for a proposal related to its Series A Convertible Preferred Stock. The ...

In a challenging turn of events for Ocean Biomedical, the company's stock has tumbled to a 52-week low, reaching a price ...

Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04 ...

US Med-Equip (USME) the nation’s highest-rated provider of medical equipment rentals, sales, biomedical support and asset management service, teamed up with Zopec Medical to help hospitals power ...

The BioArc Ultra will be installed into UK Biocentre's 70,000 square-foot facility in Milton Keynes, England, which specializes in the management and processing of biological samples. Currently ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

GE HealthCare announces the launch of a Care Innovation Hub, a joint research collaboration with the University of California ...

Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...